プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Emanuele A.に依頼

India

Expert in HTA & Market Access, Health Policy, Evidence Generation, Digital Health & Stakeholder Engagement Leadership

プロフィール概要

Independent Consultant | Market Access & HTA | Evidence Generation Strategy | Digital Health & AI in Healthcare I help small and medium-sized pharma, medtech, and digital health companies navigate the complex European market access and HTA landscape. With 10+ years of experience in EU health policy, HTA procedures, evidence synthesis, and digital health, I design and implement evidence-generation and market access strategies that accelerate adoption and reimbursement across European markets. Core expertise: - HTA Policy, Regulations & national HTA requirements - Market access strategy for SMEs and scale-ups in life sciences - Evidence synthesis & generation planning (clinical & economic) for innovative therapies and technologies - Digital health reimbursement pathways (DiGA in Germany, PECAN in France, NHS pilots, Nordic programs) - AI-driven health technologies: regulatory, evidence, and access implications - Stakeholder engagement with payers, clinicians, patients, and policymakers to shape access strategies - Policy & Consensus research leadership: Delphi studies and collaborative frameworks to inform HTA and access decisions across Europe What I offer - Strategic advice on early access planning & HTA readiness - Stakeholder engagement strategies that align company goals with payer and policy expectations - Tailored training workshops for SME teams on evidence and access requirements - Lead on evidence synthesis projects, including (systematic) literature reviews, HTA landscape assessment, policy analysis, and stakeholder mapping - Lead on consensus-building methods to generate actionable insights for cross-functional teams (clinical, medical affairs, patient engagement, and HTA & Access), including Delphi Panels, Nominal Group Technique, Focus Groups, and Advisory Boards - Support in dossier preparation, evidence gap analysis, and payer communication - Guidance for digital health startups on navigating reimbursement and evidence frameworks in Europe If you are a growing life sciences (pharma or medtech) or digital health company looking to strengthen your market access strategy, stakeholder engagement, and evidence base in Europe, I can provide practical, tailored support to help you reach patients faster and influence HTA and access environments effectively.

専門分野

• ☆ Health Policy
• ☆ Health Technology Assessment
• ☆ E-Health & Telemedicine
• ☆ Healthcare Administration & Management
• ☆ Medical Affairs
• ☆ Healthcare Reimbursement
• ☆ Literature Review
• ☆ Systematic Literature Review

サービス

• Writing
• Research

Writing Medical Writing, Technical Writing, Creative Writing

Research Market Research, Feasibility Study, Gap Analysis, Gray Literature Search, Scientific and Technical Research, Systematic Literature Review, Secondary Data Collection

職務経験

JCA Project Manager

UCB Pharmaceutical Company

8月 2025 - 現在

Researcher & Policy Advisor

Italian Society of AI in Medicine (SIIAM)

6月 2024 - 現在

Senior Consultant & Scientific Office Lead

Open Health

3月 2018 - 8月 2025

学歴

Pharmaceutical Policy Summer School

Utrecht University

6月 2019 - 7月 2019

Health Economics, Policy, and Law

Erasmus University Rotterdam

9月 2017 - 9月 2018

European Public Health

Maastricht University

9月 2014 - 8月 2017

認定資格

• 認定資格の詳細は未入力です。

出版物

JOURNAL ARTICLE

Emanuele Arcà, Dorothea Heldt, Martina Smith (2025). Comparison of health technology assessments for digital therapeutics in Germany, the United Kingdom and France . DIGITAL HEALTH.